Precision Begins at
the Genome
3B+
Base Pairs
20K+
Clinical Genes
100%
Patient-Centered
Board
Certified Standard
Ge·nom·ics
/ jəˈnōmiks / · noun
noun · precision scienceThe branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes and the clinical application of that knowledge to human health.
Origin
From Greek genesis (origin) + -ome (complete set). First used in 1986 by scientist Tom Roderick to describe the science of mapping entire genetic sequences.
The Genomics Department at the American Board of Precision Medicine translates the science of the human genome into actionable clinical knowledge - equipping physicians to interpret genetic data, identify hereditary risk, and personalize care at the molecular level.
From whole-genome sequencing and variant interpretation to pharmacogenomics and hereditary cancer risk, this department bridges the gap between laboratory discovery and bedside practice - training clinicians in the tools that define the future of medicine.
Grounded in rigorous board standards and driven by an interdisciplinary framework, genomics at ABOPM is not a subspecialty - it is the foundation of precision care.
3B+
Base Pairs Mapped
20K+
Protein-Coding Genes
∞
Clinical Possibilities
Where the Genome Meets
Clinical Purpose
The Genomics Department at ABOPM exists at the intersection of molecular science and patient care — training physicians to decode the genome, apply its insights, and transform outcomes across every clinical specialty.
Advancing research in whole-genome sequencing, variant pathogenicity, and epigenomic profiling — expanding our understanding of the genetic architecture of human disease.
Bridging the gap between laboratory genomics and bedside medicine — developing board-certified frameworks for pharmacogenomics, hereditary risk, and precision therapeutics.
Building the next generation of genomics-fluent clinicians through rigorous board standards, interdisciplinary training, and collaboration across medicine and molecular science.
"The genome is not destiny — it is a map. The Genomics Department at ABOPM trains physicians to read it, interpret it, and act on it with precision and purpose."
— American Board of Precision Medicine · Genomics DepartmentTranslating the Genome
Into Clinical Impact
The genome is the most complete biological map of a human being ever assembled. Learning to read it is not optional for the future of medicine — it is foundational.
Genomics equips clinicians to move beyond symptom management and into the molecular root causes of disease — enabling earlier detection, more precise therapeutics, and care that is truly individualized at the DNA level.
By mastering genomics, clinicians gain the power to:
Why Genomics Fluency Is Non-Negotiable
The science is here. The clinical tools are ready. The question is, are you?
Genomics-guided care demonstrably improves survival rates, reduces adverse drug reactions, and enables true preventive medicine.
Genome sequencing costs have dropped 99.9%. Genomic data is now routinely generated, clinicians who can't interpret it will be left behind.
Board certification in genomics establishes you as a recognized leader, differentiating your expertise in an era where precision medicine is standard of care.
Genomics connects every specialty: oncology, cardiology, neurology, reproductive medicine - giving you tools that transcend clinical silos.
Active research areas driving genomic medicine forward:
The genomic revolution is not a future event - it is happening now. Whole genome sequencing, pharmacogenomics, and polygenic risk modeling are actively reshaping how disease is detected, treated, and prevented at the molecular level.
The ABOPM Genomics Department positions clinicians at the center of this transformation - equipping them with the scientific literacy, clinical frameworks, and board-certified credentials to lead genomic medicine in any specialty.
Meet Our Leadership
— Director of Genomics —
Puya Yazdi, MD
Dr. Yazdi completed his medical training at USC and residency at Stanford University, later becoming a Clinical Fellow in regenerative medicine at UC Irvine. His clinical foundation spans the intersection of genomics, bioinformatics, and artificial intelligence.
As founder of Systomic Health and a leader at SelfDecode, he has pioneered genomic technologies adopted by biotechnology companies and global health platforms — driving a new era of personalized, precision medicine.
Tyler Panzner, PhD
Dr. Panzner earned a BS in Cellular & Molecular Biology from the University of South Florida and a PhD in Molecular & Cellular Pharmacology from Stony Brook University. His doctoral research focused on extracellular vesicles and their role in breast cancer metastasis and tumor-immune crosstalk.
After analyzing his own genome and resolving chronic health issues through targeted nutrition and lifestyle changes, he founded Holistic Genetic Health Solutions. His educational platform on safe supplementation reaches over 3 million monthly viewers across social media.
Gregory Nacarelli, ND, PhD
Dr. Nacarelli earned his Doctor of Naturopathic Medicine from Bastyr University, a Master's in individualized genomics & health from Johns Hopkins University, and a PhD in healthcare genetics & genomics from Clemson University. His dissertation focused on nutrigenomics, metabolomics, and cardiovascular disease.
He works as a precision health consultant with Theriome and SelfDecode, seeing clients for precision health consults while educating practitioners on applying precision health and nutrigenomics in clinical care.
Faculty Members
Our faculty roster is growing — announcements coming soon.
Faculty position open
Faculty position open
Faculty position open
Faculty position open
Think you're the right fit for a faculty position?
Get Involved →
Shaping the Future
of Precision Medicine
As precision medicine continues to evolve, genomics will play an increasingly central role in redefining how disease is understood, predicted, and treated at the molecular level.
The Genomics Department at ABOPM remains committed to advancing this field through scientific leadership, clinical innovation, and collaborative discovery. Together with our global community of physicians and researchers, we are helping shape the future of next-generation healthcare.
Insights Shaping
Precision Medicine
Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.
How Biomarker-Guided Medicine Is Changing Everyday Clinical Care
Advances in biomedical research have significantly expanded the role of molecular and physiological indicators in clinical decision-making. Among the most influential of these developments is the incr... ...more
Precision Medicine in Action
April 08, 2026•8 min read
The Rise of Precision Oncology: How Genomics Is Transforming Cancer Care
Cancer has long been recognized as a biologically heterogeneous disease, yet historically it has often been treated using relatively uniform therapeutic approaches. ...more
Precision Oncology
April 02, 2026•9 min read
Building Better Risk Prediction Models Across Populations
Risk prediction models play a central role in modern preventive medicine. These models estimate the probability that an individual will develop a specific disease over a defined time period. ...more
Population Precision
March 26, 2026•8 min read
Stay at the Forefront of Precision Medicine
Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
Advancing education, certification, and leadership to shape a genomics-driven, data-intelligent future of healthcare.
COMPANY
RESOURCES
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.